All Stories

  1. Transplantation experience as a predictor for quality of life during the first 6 months after lung transplantation
  2. Pulmonary hypertension is not a risk factor for grade 3 primary graft dysfunction after lung transplantation
  3. Evolution of lung and kidney allograft function in patients receiving kidney after lung transplantation
  4. A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature
  5. Lung transplant recipients on long-term extracorporeal photopheresis
  6. Echocardiography accurately predicts pulmonary hypertension in patients with advanced lung disease
  7. Conservative management of distal leg necrosis in lung transplant recipients
  8. Esophagopericardial fistula, septic shock and intracranial hemorrhage with hydrocephalus after lung transplantation
  9. Lumacaftor-Ivacaftor Combination Therapy in Phe508del Homozygous CF Lung Transplant Candidates - Preliminary Results
  10. Effect of Gender Mismatch on Outcome in Lung Transplantation
  11. Lung Transplantation with Controlled Donation After Circulatory Death Donors: Initial Experience in Switzerland
  12. Is There a Rationale for an “Old-for-Old” Program in Lung Transplantation? A Comparative Study Using the International Society of Heart and Lung Transplantation Database
  13. Transplant center volume and outcomes in lung transplantation for cystic fibrosis
  14. The Impact of Donor Age on Post–Lung Transplant Survival: How Far Can We Go?
  15. Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment
  16. Prevalence of gastrointestinal dysmotility and complications detected by abdominal plain films after lung transplantation: a single-centre cohort study
  17. Host-microbe interactions in the transplanted lung
  18. Extracorporeal Life Support as Bridge to Lung Retransplantation: A Multicenter Pooled Data Analysis
  19. Long-term follow-up of lung transplant recipients supports non-operative treatment of uncomplicated diverticulitis
  20. Oxygen-enhanced MR (OE-MR): Correlation to CT Brody score in cystic fibrosis patients
  21. Insulin secretion abnormalities in patients with cystic fibrosis
  22. Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation
  23. Is total hip arthroplasty safely performed in lung transplant patients? Current experience from a retrospective study of the Zurich lung transplant cohort
  24. Human metapneumovirus in lung transplant recipients: characteristics and outcomes
  25. Isolation ofStenotrophomonas maltophiliain asymptomatic lung transplant recipients: effects of treatment on eradication and outcome
  26. Diagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytology
  27. 216 Evaluation of care in CF patients undergoing transition from paediatric to adult care in Zurich
  28. Therapeutic options for bronchiolitis obliterans Syndrome after lung transplantation
  29. Special considerations for the use of lung transplantation in pediatrics
  30. Immediate and Underlying Causes of Death in Lung Transplant Recipients With and Without Chronic Lung Allograft Dysfunction
  31. Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation
  32. The Prognostic Value of Blood Eosinophilia on Survival After Restrictive CLAD Diagnosis
  33. Does Donor Age Impact Recipient Survival Post-Lung Transplant: A Study of the International Society of Heart and Lung Transplantation Database
  34. Age Trends for Cystic Fibrosis Patients Undergoing Lung Transplantation: An Analysis of the ISHLT Thoracic Transplant Registry
  35. HbA1c: An effective screening tool for cystic fibrosisrelated diabetes?
  36. The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary
  37. Impact of time interval between donor brain death and cold preservation on long-term outcome in lung transplantation
  38. CME: Lymphoproliferative Erkrankung nach Transplantation (PTLD)
  39. Lungentransplantation bei Patienten mit interstitieller Lungenerkrankung/idiopathisch pulmonaler Fibrose
  40. CME-Antworten zu den Fragen zu «Lymphoproliferative Erkrankung nach Transplantation (PTLD)» aus Praxis Nr. 3
  41. Favorable outcome of children and adolescents undergoing lung transplantation at a European adult center in the new era
  42. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation
  43. Physical Activity and Exercise Training in Lung Transplant Recipients with Cystic Fibrosis: ‘What We Know, What We Don’t Know and Where to Go’
  44. Unbiased metagenomic sequencing complements specific routine diagnostic methods and increases chances to detect rare viral strains
  45. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report—2015; Focus Theme: Early Graft Failure
  46. The Registry of the International Society for Heart and Lung Transplantation: Eighteenth Official Pediatric Lung and Heart-Lung Transplantation Report—2015; Focus Theme: Early Graft Failure
  47. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report—2015; Focus Theme: Early Graft Failure
  48. Exposure to moxifloxacin and cytomegalovirus replication is associated with skin squamous cell carcinoma development in lung transplant recipients
  49. Alveolar macrophages and pulmonary microbiota are interconnected indicators of lung ecology post-transplantation
  50. Risk factors for chronic lung allograft dysfunction (CLAD) in the SysCLAD cohort
  51. Outcome of Extracorporeal Membrane Oxygenation as a Bridge To Lung Transplantation
  52. P-285LONG-TERM INDWELLING PLEURAL CATHETER AS AN AMBULATORY TREATMENT FOR RECURRENT PNEUMOTHORACES IN A PATIENT WITH CHRONIC LUNG ALLOGRAFT DYSFUNCTION
  53. F-126THE IMPACT OF DONOR COMORBIDITIES IN PREDICTING LONG-TERM SURVIVAL IN LUNG TRANSPLANTATION: THE ZURICH DONOR SCORE
  54. Adenocarcinoma of the gastrointestinal tract in lung transplanted patients with cystic fibrosis: case series and review of the literature
  55. Psychological distress and quality of life in lung transplant patients. A six-month observational study
  56. What we expected all along: Bronchiolitis obliterans syndrome is not specific for bronchiolitis obliterans in pediatric lung transplantation!
  57. Hepatitis FromSpiroplasmasp. in an Immunocompromised Patient
  58. Managing Viral Respiratory Tract Infections in Lung Transplant Recipients
  59. Coronary Artery Disease in Lung Transplant Candidates: Role of Routine Invasive Assessment
  60. Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation
  61. A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
  62. The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Adult Lung and Heart–Lung Transplant Report—2014; Focus Theme: Retransplantation
  63. The Registry of the International Society for Heart and Lung Transplantation: Seventeenth Official Pediatric Heart Transplantation Report—2014; Focus Theme: Retransplantation
  64. The Registry of the International Society for Heart and Lung Transplantation: Seventeenth Official Pediatric Lung and Heart–Lung Transplantation Report—2014; Focus Theme: Retransplantation
  65. The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Official Adult Heart Transplant Report—2014; Focus Theme: Retransplantation
  66. P-227 * LUNG TRANSPLANTATION FOR EMPHYSEMA: IMPACT OF AGE ON SHORT- AND LONG-TERM SURVIVAL
  67. WS8.3 Extracorporeal life support as a bridge to lung transplantation: outcome in cystic fibrosis recipients
  68. Antifungal prophylaxis in pediatric lung transplantation: An international multicenter survey
  69. Outcome of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation: Institutional Experience
  70. Phenotypes of Chronic Lung Allograft Dysfunction (CLAD): A Multilevel Diagnostic Approach
  71. Orthostatic Hypotension Appears to be Common Among Lung Transplant Recipients
  72. Intra-operative extracorporeal membrane oxygenation use in pediatric lung transplantation - The Zurich experience
  73. A New Heterotopic Transplant Animal Model of Intestinal Fibrosis
  74. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report—2013; Focus Theme: Age
  75. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report—2013; Focus Theme: Age
  76. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth Official Pediatric Heart Transplantation Report—2013; Focus Theme: Age
  77. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth Official Pediatric Lung and Heart-Lung Transplantation Report—2013; Focus Theme: Age
  78. Simultaneous Bilateral Lobar Lung Transplantation: One Donor Serves Two Recipients
  79. 265 Prevalence and treatment of reduced BMD in a cystic fibrosis cohort undergoing lung transplantation
  80. Practical approach to early postoperative management of lung transplant recipients
  81. Characteristics and Outcome of Influenza Infections in Lung Transplant Recipients: A Single Season Cohort Study
  82. Anti-Fungal Prophylaxis in Pediatric Lung Transplantation – An International Multi-Center Survey
  83. Body mass index and its effect on outcome in children after lung transplantation
  84. Impact of Sinus Surgery on Pseudomonal Airway Colonization, Bronchiolitis Obliterans Syndrome and Survival in Cystic Fibrosis Lung Transplant Recipients
  85. Specific aspects of children and adolescents undergoing lung transplantation
  86. The Registry of the International Society for Heart and Lung Transplantation: 29th Adult Lung and Heart-Lung Transplant Report—2012
  87. The Registry of the International Society for Heart and Lung Transplantation: Fifteenth Pediatric Lung and Heart-Lung Transplantation Report—2012
  88. The Registry of the International Society for Heart and Lung Transplantation: Fifteenth Pediatric Heart Transplantation Report—2012
  89. The Registry of the International Society for Heart and Lung Transplantation: 29th Official Adult Heart Transplant Report—2012
  90. RSV prevention and treatment in pediatric lung transplant patients: A survey of current practices among the International Pediatric Lung Transplant Collaborative
  91. 503 RSV Prevention and Treatment in Pediatric Lung Transplant Patients: A Survey of Current Practices among the International Pediatric Lung Transplant Collaborative (IPLTC)
  92. 507 IgM Depletion Discovers Undetected Donor Specific Antibodies Associated with Antibody Mediated Rejection after Lung Transplantation
  93. 512 Lessons from the Lung: 186 Autopsies after Lung Transplantation
  94. 817 ECMO Use in Pediatric Lung Transplantation – The Zurich Experience
  95. 511 Prospective Surveillance and Treatment of Pre-Existing Donor Specific Antibodies Ameliorates 1-Year Risk of BOS after Lung Transplantation
  96. 509 Prospective Surveillance and Treatment of De Novo Donor Specific Antibodies after Lung Transplantation Ameliorates 1-Year Risk of BOS
  97. Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation
  98. New Developments In Treatment After Lung Transplantation
  99. The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Heart Transplantation Report—2011
  100. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report—2011
  101. Lung transplantation for cystic fibrosis: a single center experience of 100 consecutive cases
  102. Persistent photodamage following drug photosensitization in a lung-transplant recipient
  103. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: Coverage, safety and clinical effectiveness in the Zurich cohort
  104. Bilateral lung transplantation for pediatric idiopathic pulmonary arterial hypertension: A multi-center experience
  105. Exercise testing in pediatric lung transplant candidates with cystic fibrosis
  106. Donor predicted post-operative forced expiratory volume in one second predicts recipients’ best forced expiratory volume in one second following size-reduced lung transplantation
  107. Body composition assessed by the 4-component model and association with lung function in 6-12-y-old children with cystic fibrosis
  108. Respiratory muscle training: Effects of training or simple learning?
  109. Extended Measurements of Exhaled Nitric Oxide in Adult Lung Transplant Recipients
  110. Body composition and lung function in young children with cystic fibrosis
  111. Longitudinal changes in bone mass in children with cystic fibrosis: effect of size adjustment using bone mineral apparent density
  112. Size-reduced lung transplantation in children - an option worth to consider!
  113. Kidney transplantation Improves Lung Function In Lung Transplant Recipients
  114. Cardiac Re-modelling In Children After Bilateral Lung Transplantation for Idiopathic pulmonary Arterial Hypertension
  115. 201: Lung Transplantation in Children after Hematopoietic Stem-Cell Transplantation
  116. 90: Body Mass Index and Its Impact on Outcome in Children after Lung Transplantation: An Analysis of the ISHLT Pediatric Lung Transplant Registry
  117. Lung Transplant Recipients and Other Immunosuppressed Patients
  118. Exercise Training in Children and Adolescents with Cystic Fibrosis: Theory into Practice
  119. Lung transplantation in children with idiopathic pulmonary arterial hypertension
  120. Paediatric aspects of lung transplantation
  121. Clinical models of tolerance induction in pediatric transplantation
  122. Long-Term Clarithromycin Therapy in the Management of Lung Transplant Recipients
  123. Pediatric Transplantation: Ten years on
  124. True Survival Benefit of Lung Transplantation for Cystic Fibrosis Patients: The Zurich Experience
  125. Chronic kidney disease in children following lung and heart-lung transplantation
  126. Role of Sensory Neuropeptides in PIV-3-lnfection-lnduced Airway Hyperresponsiveness in Guinea Pigs
  127. Clinical Exercise Testing in Children and Adolescents with Cystic Fibrosis
  128. Lung Transplantation for Lymphangioleiomyomatosis: The European Experience
  129. Extracorporeal Photopheresis After Lung Transplantation: A 10-Year Single-Center Experience
  130. Undercarboxylated osteocalcin and bone mass in 8–12 year old children with cystic fibrosis
  131. Pediatric lung transplantation: Literature review 2006-2007
  132. Lung transplantation and survival in children with cystic fibrosis: Solid statistics - Flawed interpretation
  133. Variability in immunization guidelines in children before and after lung transplantation
  134. Surveillance bronchoscopy in children during the first year after lung transplantation: is it worth it?
  135. 20
  136. Monitoring of Epstein–Barr Viral Load in Pediatric Heart and Lung Transplant Recipients by Real-time Polymerase Chain Reaction
  137. The Chrispin-Norman score in cystic fibrosis: doing away with the lateral view
  138. High prevalence of gastroesophageal reflux in children post lung transplantation-a single center experience
  139. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real time PCR